Kyocera Medical Technologies: Acetabular joint liner tech with ‘ceramic-like’ wettability
Kyoto, Japan-based Kyocera Medical Technologies (TYO:6971) touted its Aquala acetabular joint liner technology as having “ceramic-like” wettability in highly crosslinked UHMWPE for improved wear. Kyocera said it designed Aquala to create an exceptionally low-friction bearing surface on the acetabular side of the hip joint, which couples with diamond-polished ceramic on the femoral side.
The company developed the technology with the University of Tokyo to reduce wear debris and extend the life of artificial hip implants. Hip joints using Aquala technology have been used in approximately 45,000 total hip replacements worldwide, and are under review by FDA, with 510(k) clearance expected this year.